跳至主要内容
临床试验/ISRCTN14693054
ISRCTN14693054已完成未知

A randomised crossover design study comparing the pharmacokinetics and pharmacodynamics of two single Doses of ORal Aspirin (75 mg v150 mg) in pregnant women at risk of pre-eclampsia (DORA)

ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 16 人开始时间: 2021年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Pregnant women at risk of pre-eclampsia according to NICE criteria

排除标准

  • 1. Hypersensitivity to aspirin, salicylic acid compounds, or prostaglandin synthase inhibitors (e.g. certain asthma patients who may suffer an attack or faint)
  • 2. Active, or history of, recurrent peptic ulcer and/or gastric/intestinal haemorrhage, or other kinds of bleeding such as cerebrovascular haemorrhage
  • 3. Haemorrhagic diathesis or coagulation disorders such as hemophilia and thrombocytopenia
  • 4. Severe hepatic or renal impairment
  • 6. Taken aspirin over the preceding 4 weeks
  • 7. Current anticoagulant therapy
  • 8. Unable to give informed consent
  • 9. Multiple pregnancy
  • 10. Known fetal anomaly
  • 11. Vegetarian/vegan diet

研究者

发起方
ewcastle upon Tyne Hospitals NHS Foundation Trust

相似试验